Want to join the conversation?
$LCI said that it recently received approval from the U.S. FDA of its Abbreviated New Drug Application (ANDA) for Paroxetine extended release tablets USP, 12.5 mg, 25 mg and 37.5 mg. According to IMS, total U.S. sales in 2015 of these tablets at average wholesale price were approx. $122MM. $LCI said it has begun shipping product to customers.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.